Apollomics Inc. Warrant
Apollomics, Inc., a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, … Read more
Market Cap & Net Worth: Apollomics Inc. Warrant (APLMW)
Apollomics Inc. Warrant (NASDAQ:APLMW) has a market capitalization of $126.71 ($126.71) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #49943 globally and #15246 in its home market, demonstrating a 6.92% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Apollomics Inc. Warrant's stock price $0.01 by its total outstanding shares 9116 (9.12K).
Apollomics Inc. Warrant Market Cap History: 2023 to 2026
Apollomics Inc. Warrant's market capitalization history from 2023 to 2026. Data shows change from $227.90 to $126.71 (-50.38% CAGR).
Apollomics Inc. Warrant Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Apollomics Inc. Warrant's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Apollomics Inc. Warrant's market cap is 0.00 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $227.90 | $821.00K | -$172.60 Million | 0.00x | N/A |
Competitor Companies of APLMW by Market Capitalization
Companies near Apollomics Inc. Warrant in the global market cap rankings as of March 18, 2026.
Key companies related to Apollomics Inc. Warrant by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Apollomics Inc. Warrant Historical Marketcap From 2023 to 2026
Between 2023 and today, Apollomics Inc. Warrant's market cap moved from $227.90 to $ 126.71, with a yearly change of -50.38%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $126.71 | +25.23% |
| 2025 | $101.19 | +20.65% |
| 2024 | $83.87 | -63.20% |
| 2023 | $227.90 | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Apollomics Inc. Warrant was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $126.71 USD |
| MoneyControl | $126.71 USD |
| MarketWatch | $126.71 USD |
| marketcap.company | $126.71 USD |
| Reuters | $126.71 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.